Pathological findings after long-term sulfonylurea therapy.
D007516:Adenoma, Islet Cell / Q000473:pathology; D000368:Aged; D002561:Cerebrovascular Disorders / Q000473:pathology; D003920:Diabetes Mellitus / Q000473:pathology*; D003928:Diabetic Nephropathies / Q000473:pathology; D003930:Diabetic Retinopathy / Q000473:pathology; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D009203:Myocardial Infarction / Q000473:pathology; D009369:Neoplasms / Q000473:pathology; D010437:Peptic Ulcer / Q000473:pathology; D012189:Retrospective Studies; D013959:Thyroid Diseases / Q000473:pathology
D007004:Hypoglycemic Agents